சுஷிலா கட்டாரியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சுஷிலா கட்டாரியா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சுஷிலா கட்டாரியா Today - Breaking & Trending Today

Doctors call monoclonal antibody cocktail 'first Covid treatment'


Doctors call monoclonal antibody cocktail ‘first Covid treatment’
SECTIONS
Share
Synopsis
The antibody cocktail is a combination of Casirivimab and Imdevimab, which are laboratory made monoclonal antibodies. The cocktail works just like antibodies produced in the human body in response to any viral infection.
Getty Images
The initial use of monoclonal antibody cocktail, the combination of drugs used on former US President Donald Trump and given emergency use approval in India in early May, has given encouraging results, with doctors involved touting it as the “first real treatment for Covid-19”.
Eight-four-year-old Mohabbat Singh, a resident of Haryana, was the first patient in India to be administered the antibody drug cocktail at Medanta Medicity, Gurugram, on May 25. The doctor treating him, Sushila Kataria, told ET, “the patient has tested negative. We have administered the drug cocktail to 15 patients so far. All are fine. This is the fir ....

Madhya Pradesh , Rajesh Chawla , Medanta Medicity , Sushila Kataria , Donald Trump , Zafar Ahmed , Indraprastha Apollo , Mohabbat Singh , Fortis Hospital Mohali , Hepatitis C , மத்யா பிரதேஷ் , ராஜேஷ் சாவ்லா , மேதாண்த மருந்து , சுஷிலா கட்டாரியா , டொனால்ட் துருப்பு , இந்திரபிரஸ்தா அப்பல்லோ , மோஹ்ப்பட் சிங் , கோட்டை மருத்துவமனை மொஹாலி ,

Haryana man, 84, first Indian to get Trump cocktail | India News


NEW DELHI: Mohabbat Singh, 84, from Haryana has become the first person in India to be administered the “famous” Covid drug cocktail given to former US president Donald Trump. Singh, who has been under treatment for the past five days, was given the drug over 30-minute intravenous supply on Tuesday at Medanta, Gurugram.
The drug, Regeneron, is touted as a breakthrough treatment for certain patients as it shortens symptom duration and reduces viral load by fast acting antibodies.
The first batch of the Roche drug with two antibodies Casirivimab and Imdevimab reached India on Monday. “This drug is different from convalescent plasma and entirely different from repurposed drugs like Remdesivir or Tocilizumab. Studies show that 80% of patients who took this drug didn’t need hospitalisation, and it also reduced death rate in addition to shortening the duration of symptoms,” Dr Naresh Trehan, director, Medanta, told TOI. ....

Sushila Kataria , Donald Trump , Naresh Trehan , Mohabbat Singh , சுஷிலா கட்டாரியா , டொனால்ட் துருப்பு , னரேஷ் திர்ேன் , மோஹ்ப்பட் சிங் ,